AVVH Quote, Financials, Valuation and Earnings

Consumer Portfolio Services has a net margin of -- compared to AVVAA World Health Care Products's net margin of 9.04%. AVVAA World Health Care Products's return on equity of -- beat Consumer Portfolio Services's return on equity of 6.72%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Consumer Portfolio Services has an analysts' consensus of $15.00 which suggests that it could grow by 58.4%. Given that Consumer Portfolio Services has higher upside potential than AVVAA World Health Care Products, analysts believe Consumer Portfolio Services is more attractive than AVVAA World Health Care Products.

AVVAA World Health Care Products has a beta of 1.879, which suggesting that the stock is 87.905% more volatile than S&P 500. In comparison Consumer Portfolio Services has a beta of 0.951, suggesting its less volatile than the S&P 500 by 4.886%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Consumer Portfolio Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Consumer Portfolio Services pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Consumer Portfolio Services quarterly revenues of $52M. AVVAA World Health Care Products's net income of -- is lower than Consumer Portfolio Services's net income of $4.7M. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Consumer Portfolio Services's PE ratio is 11.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 1.12x for Consumer Portfolio Services. Usually stocks with elevated PS ratios are considered overvalued.

EZCORP has a net margin of -- compared to AVVAA World Health Care Products's net margin of 8.29%. AVVAA World Health Care Products's return on equity of -- beat EZCORP's return on equity of 10.97%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand EZCORP has an analysts' consensus of $21.00 which suggests that it could grow by 47.68%. Given that EZCORP has higher upside potential than AVVAA World Health Care Products, analysts believe EZCORP is more attractive than AVVAA World Health Care Products.

AVVAA World Health Care Products has a beta of 1.879, which suggesting that the stock is 87.905% more volatile than S&P 500. In comparison EZCORP has a beta of 0.519, suggesting its less volatile than the S&P 500 by 48.074%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EZCORP offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. EZCORP pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than EZCORP quarterly revenues of $306.3M. AVVAA World Health Care Products's net income of -- is lower than EZCORP's net income of $25.4M. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while EZCORP's PE ratio is 11.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 0.99x for EZCORP. Usually stocks with elevated PS ratios are considered overvalued.

Federal Home Loan Mortgage has a net margin of -- compared to AVVAA World Health Care Products's net margin of 47.74%. AVVAA World Health Care Products's return on equity of -- beat Federal Home Loan Mortgage's return on equity of 21.07%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Federal Home Loan Mortgage has an analysts' consensus of $3.25 which suggests that it could fall by -56.67%. Given that Federal Home Loan Mortgage has higher upside potential than AVVAA World Health Care Products, analysts believe Federal Home Loan Mortgage is more attractive than AVVAA World Health Care Products.

AVVAA World Health Care Products has a beta of 1.879, which suggesting that the stock is 87.905% more volatile than S&P 500. In comparison Federal Home Loan Mortgage has a beta of 1.999, suggesting its more volatile than the S&P 500 by 99.929%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Federal Home Loan Mortgage offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Federal Home Loan Mortgage pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Federal Home Loan Mortgage quarterly revenues of $5.9B. AVVAA World Health Care Products's net income of -- is lower than Federal Home Loan Mortgage's net income of $2.8B. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Federal Home Loan Mortgage's PE ratio is 3,344.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 1.01x for Federal Home Loan Mortgage. Usually stocks with elevated PS ratios are considered overvalued.

Mag Mile Capital has a net margin of -- compared to AVVAA World Health Care Products's net margin of 1.25%. AVVAA World Health Care Products's return on equity of -- beat Mag Mile Capital's return on equity of -305%.

AVVAA World Health Care Products has a consensus price target of --, signalling downside risk potential of --. On the other hand Mag Mile Capital has an analysts' consensus of -- which suggests that it could fall by --. Given that AVVAA World Health Care Products has higher upside potential than Mag Mile Capital, analysts believe AVVAA World Health Care Products is more attractive than Mag Mile Capital.

AVVAA World Health Care Products has a beta of 1.879, which suggesting that the stock is 87.905% more volatile than S&P 500. In comparison Mag Mile Capital has a beta of 2.404, suggesting its more volatile than the S&P 500 by 140.37%.

AVVAA World Health Care Products has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mag Mile Capital offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVVAA World Health Care Products pays -- of its earnings as a dividend. Mag Mile Capital pays out -- of its earnings as a dividend.

AVVAA World Health Care Products quarterly revenues are --, which are smaller than Mag Mile Capital quarterly revenues of $780.5K. AVVAA World Health Care Products's net income of -- is lower than Mag Mile Capital's net income of $9.7K. Notably, AVVAA World Health Care Products's price-to-earnings ratio is -- while Mag Mile Capital's PE ratio is 771.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVVAA World Health Care Products is -- versus 12.26x for Mag Mile Capital. Usually stocks with elevated PS ratios are considered overvalued.